Literature DB >> 18717013

High-resolution analysis of genomic profiles of hepatocellular carcinoma cells with differential osteopontin expression.

Bingsheng Sun1, Jincai Wu, Ti Zhang, Changli Wang.   

Abstract

Overexpression of osteopontin (OPN) could contribute to tumorigenesis and metastasis in hepatocellular carcinoma (HCC). Previous studies have shown that OPN-positive cancer cells are often localized in the periphery of cancer nodules adjacent to stromal cells. To identify the difference in intratumor genomic aberration pattern between OPN-positive and OPN-negative HCC cells, we adopted microarray-based comparative genomic hybridization (array-CGH) to achieve high-resolution analysis of genome-wide aberrations. Our present study indicates that, compared to OPN-negative cancer cells, OPN-positive cancer cells show much more amplification of chromosomal regions, including 4q13.1-q13.3, 4q21.23-q22.1 and 13q32.1-q32.3. Some candidate tumor related genes, such as SMR3B, MUC7, EPHA5, SPP1 and CLDN10, were detected with over 1.5-fold amplification. Together, the intratumor genomic heterogeneity may suggest that OPN-positive cancer cells play a more important role in the development of HCC malignancy than their OPN-negative counterparts.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18717013     DOI: 10.4161/cbt.7.3.5365

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  4 in total

1.  Genes with relevance for early to late progression of colon carcinoma based on combined genomic and transcriptomic information from the same patients.

Authors:  Kristina K Lagerstedt; Erik Kristiansson; Christina Lönnroth; Marianne Andersson; Britt-Marie Iresjö; Annika Gustafsson; Elisabeth Hansson; Ulf Kressner; Svante Nordgren; Fredrik Enlund; Kent Lundholm
Journal:  Cancer Inform       Date:  2010-04-23

2.  Downregulation of EphA5 by promoter methylation in human prostate cancer.

Authors:  Shibao Li; Yingfeng Zhu; Chunguang Ma; Zhenhua Qiu; Xinju Zhang; Zhihua Kang; Zhiyuan Wu; Hua Wang; Xiao Xu; Hu Zhang; Guoqiang Ren; Jianmin Tang; Xiangyu Li; Ming Guan
Journal:  BMC Cancer       Date:  2015-01-22       Impact factor: 4.430

3.  Unique structure and dynamics of the EphA5 ligand binding domain mediate its binding specificity as revealed by X-ray crystallography, NMR and MD simulations.

Authors:  Xuelu Huan; Jiahai Shi; Liangzhong Lim; Sayantan Mitra; Wanlong Zhu; Haina Qin; Elena B Pasquale; Jianxing Song
Journal:  PLoS One       Date:  2013-09-24       Impact factor: 3.240

4.  EphA5 knockdown enhances the invasion and migration ability of esophageal squamous cell carcinoma via epithelial-mesenchymal transition through activating Wnt/β-catenin pathway.

Authors:  Rui Zhang; Jing Liu; Wei Zhang; Lei Hua; Li-Ting Qian; Shao-Bing Zhou
Journal:  Cancer Cell Int       Date:  2020-01-13       Impact factor: 5.722

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.